Phosphodiesterase type 5 inhibitor (sildenafil) - impact in proliferative diabetic retinopathy? Korhonen A, Gucciardo E, Lehti K, Loukovaara S, et al. Acta Ophthalmol 2021 Nov 8. doi: 10.1111/aos.15058.

Read + Share

Amedeo Smart

Independent Medical Education

Korhonen A, Gucciardo E, Lehti K, Loukovaara S, et al. Phosphodiesterase type 5 inhibitor (sildenafil) - impact in proliferative diabetic retinopathy? Acta Ophthalmol 2021 Nov 8. doi: 10.1111/aos.15058.
PMID: 34750980